Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Supporting your high street Find out how »
Genome-Based Diagnostics : Demonstrating Clinical Utility in Oncology: Workshop Summary, Paperback / softback Book

Genome-Based Diagnostics : Demonstrating Clinical Utility in Oncology: Workshop Summary Paperback / softback

Edited by Steve Olson, Adam C. Berger

Paperback / softback

Available to Order - This title is available to order, with delivery expected within 2 weeks

Description

Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology is the summary of a workshop convened in May 2012 by the Roundtable on Translating Genomic-Based Research for Health and the Center for Medical Technology Policy of the Institute of Medicine to foster the identified need for further sustained dialogue between stakeholders regarding the clinical utility of molecular diagnostics.

The workshop brought together a wide range of stakeholders, including patients, health care providers, policy makers, payers, diagnostic test developers, researchers, and guideline developers, to identify the challenges and opportunities in advancing the development and use of molecular diagnostic tests designed to guide the treatment and management of patients with cancer. The sequencing of the human genome has greatly accelerated the process of linking specific genetic variants with disease.

These findings have yielded a rapidly increasing number of molecular diagnostic tests designed to guide disease treatment and management.

Many of these tests are aimed at determining the best treatments for specific forms of cancer, making oncology a valuable testing ground for the use of molecular diagnostic tests in medicine in general.

Nevertheless, many questions surround the clinical value of molecular diagnostic tests, and their acceptance by clinicians, payers, and patients has been unpredictable.

A major limiting factor for the use of these tests has been the lack of clear evidence of clinical utility.

Genome-Based Diagnostics assesses the evidentiary requirements for clinical utility of molecular diagnostics used to guide treatment decisions for patients with cancer; discusses methodologies related to demonstrating these evidentiary requirements that meet the needs of all stakeholders; and considers innovative, sustainable research collaborations for generating evidence of clinical utility involving multiple stakeholders. Table of ContentsFront Matter1 Introduction2 Setting the Context3 Perspectives from Stakeholders4 Tools for Generating and Synthesizing Evidence5 Advancing Molecular Diagnostics for OncologyReferencesAppendix A: Workshop AgendaAppendix B: Speaker Biographical SketchesAppendix C: Statement of TaskAppendix D: Registered Attendees

Information

Other Formats

Save 0%

£32.00

£31.85

Available to Order - This title is available to order, with delivery expected within 2 weeks
Add to Basket
Sign in to add to wishlist
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information